those 8M shares weren't sold in total (open mkt) .. and the proof is in the volume (lack of)
facts are a funny thing .. SMBs get utilized to work retails' emotions
because retail (for the most part) isn't part of a crew working .. either with those who do collude and illegally manipulate OTC *targets* .. or other like minded *entities*
but it is always interesting who uses certain terminology *consistently thru out the years* .. to say nothing of the patterns' displayed by some
NR (non retail) embeds SMBs .. because while an OTC target is being worked for its cycle of money .. most i suspect can understand the concept of working a stock (liquidity) both UP and DOWN .. and because NR can flat out abusively short to (she laughs) make a market .. courtesy of that toothless tiger .. the SEC
now what is interesting is that same paper tiger .. tasked FINRA a decade back with creating the data (reporting) for daily reg sho (not to be confused with reg sho threshold) .. but for those who can *track/observe* patterns .. beyond useful for what those patterns (all of them) >> reveal
first was the various entities utilizing a blanket ban on any info on this new reporting (link went live in Feb 2010 .. retroactive to Aug 2009) .. for months
until *entities* had reworked their talking points .. because of course for YEARs
>> embeds << had posted 1000s of posts *conditioning by rote .. retail* that there was no *shorting* on any OTC stock
think about that ..
so then when data was finally *allowed* to be posted .. NR solicited an old alias
(who was *revived* after about a 5 year hiatus) to *cyber stalk those who knew
that this data actually meant something .. if only OTC target could outlast NRs' efforts*
and so it has gone for over 8 years .. now here's the joy of understanding *patterns*
the first aspect re: this data is to try and discredit the person posting the info
let's be clear .. the majority of OTC targets .. will not survive .. especially those
that came public a decade back .. via a R/M (reverse merge) ... unlike those OTC targets that now come public via an S1 registration (which clearly have different *reporting* standards by NR) .. i suspect this *reality* pertains to prior FTDs never cleaned up in the old shells ..
speaking of FTDs .. another aspect that NR likes to trot out .. as if it means anything re: reporting on an OTC target .. first data is reported re: FTDs multiple times per month .. not 1x .. second is as has been shown via FUSZ and ACBFF
(i could point out many others .. but imo it's far wiser for actual investors in Innovation to have their curiosity piqued to understand where in the *pattern* NR actually is) FTDs mean jack sh*t on an OTC target (you can thank the SEC for their complicity) .. nor does what gets *reported* on the *legal* matter beyond the obvious
and by the obvious .. i'm noting what gets *covered* and what doesn't in that 2 week window
and this brings me to IPIX since April 2018 .. when those 8M were first *available*
some here might remember the *volume* avgs on IPIX back days b4 the 9th of April's >> 90,000 and change << and then of course the news that was noted
re: 8M and those dates ..
4.6.18
Volume (10 day Average) 90,202
Volume (90 day Average) 247,321
and today's *avgs*
6.7.18
Volume (10 day Average) 94,054
Volume (90 day Average) 210,770
logic and common sense come to mind here .. almost 2 months to the day ..
IPIX volume avgs *continue* to decline .. which tells me .. that NR hasn't sold
anywhere near what they *allegedly* had access to .. which also tells me .. retention of the majority of those shares .. is deliberate because unlike so many OTC targets .. Innovation .. alongside her investors (not traders .. not crew) have outlasted NON RETAIL .. and that is truly unique when it comes to the OTC
and that was clear to me even before we got the news of the 8M *shares* ..
which leaves NR with very few options .. left to *work*
so you see new *aliases* try to embed this SMB (the other site has been useless for a dog's age) .. you see embeds trot out FTDs (as if they actually matter on an OTC) .. you see discussion of this divisive topic brought up deliberately by those who never offer any *factual* data .. rather trot out NRs' standard lines (sound bites)
every actual Innovation Investor knows why they remain invested
unlike many here who understand the science .. i remain invested due to mgmt's aggressive response to the blatant (but predictable) attack by NR in 2015 .. after NRs' last *significant* cycle (TAKE UP) of the back half of 2014 (just below 5.00)
mgmt's awareness of this illegal stock manipulation is as vital to the company's survival as their platforms are *imo*
and while the abusive short in IPIX is *less* than it would be *imo* due to access to those shares thru out the years .. it clearly exists .. because NR would *cover* the legal short that is currently reported .. if able to .. instead NR has had to *report* an increase over the last time frame .. vs a decrease .. and the reason the volume *decreases* is that NR is literally *stuck* in a hole of their own making
they can compress the PPS .. but retail will always pick off *shares* ... making that *hole* even deeper with news out of mgmt that *cant* be manipulated *down*
so NR deals with *reality* of marking at a higher and higher % .. on less and less *volume* .. and faces *imo .. (based on years of observations*) .. triggering reg sho .. quite possibly b4 news out of mgmt
now this is where it's going to be really interesting to see how *mgmt* handles aspects .. because in their shoes .. i'd be staggering news that allows NR no respite to *regroup* .. it's doable and i'm currently invested in a few other *survivors* whose mgmt has figured out the rigged game .. which has been my point all along
retail can learn where in the cycle NR is when it comes to any investment
so one isn't reduced to *whining* on SMBs .. or trolling others who *do* understand exactly what this data reveals ..
as always .. best to actual Innovation Pharma investors
4kids
facts are a funny thing .. SMBs get utilized to work retails' emotions
because retail (for the most part) isn't part of a crew working .. either with those who do collude and illegally manipulate OTC *targets* .. or other like minded *entities*
but it is always interesting who uses certain terminology *consistently thru out the years* .. to say nothing of the patterns' displayed by some
NR (non retail) embeds SMBs .. because while an OTC target is being worked for its cycle of money .. most i suspect can understand the concept of working a stock (liquidity) both UP and DOWN .. and because NR can flat out abusively short to (she laughs) make a market .. courtesy of that toothless tiger .. the SEC
now what is interesting is that same paper tiger .. tasked FINRA a decade back with creating the data (reporting) for daily reg sho (not to be confused with reg sho threshold) .. but for those who can *track/observe* patterns .. beyond useful for what those patterns (all of them) >> reveal
first was the various entities utilizing a blanket ban on any info on this new reporting (link went live in Feb 2010 .. retroactive to Aug 2009) .. for months
until *entities* had reworked their talking points .. because of course for YEARs
>> embeds << had posted 1000s of posts *conditioning by rote .. retail* that there was no *shorting* on any OTC stock
think about that ..
so then when data was finally *allowed* to be posted .. NR solicited an old alias
(who was *revived* after about a 5 year hiatus) to *cyber stalk those who knew
that this data actually meant something .. if only OTC target could outlast NRs' efforts*
and so it has gone for over 8 years .. now here's the joy of understanding *patterns*
the first aspect re: this data is to try and discredit the person posting the info
let's be clear .. the majority of OTC targets .. will not survive .. especially those
that came public a decade back .. via a R/M (reverse merge) ... unlike those OTC targets that now come public via an S1 registration (which clearly have different *reporting* standards by NR) .. i suspect this *reality* pertains to prior FTDs never cleaned up in the old shells ..
speaking of FTDs .. another aspect that NR likes to trot out .. as if it means anything re: reporting on an OTC target .. first data is reported re: FTDs multiple times per month .. not 1x .. second is as has been shown via FUSZ and ACBFF
(i could point out many others .. but imo it's far wiser for actual investors in Innovation to have their curiosity piqued to understand where in the *pattern* NR actually is) FTDs mean jack sh*t on an OTC target (you can thank the SEC for their complicity) .. nor does what gets *reported* on the *legal* matter beyond the obvious
and by the obvious .. i'm noting what gets *covered* and what doesn't in that 2 week window
and this brings me to IPIX since April 2018 .. when those 8M were first *available*
some here might remember the *volume* avgs on IPIX back days b4 the 9th of April's >> 90,000 and change << and then of course the news that was noted
re: 8M and those dates ..
4.6.18
Volume (10 day Average) 90,202
Volume (90 day Average) 247,321
and today's *avgs*
6.7.18
Volume (10 day Average) 94,054
Volume (90 day Average) 210,770
logic and common sense come to mind here .. almost 2 months to the day ..
IPIX volume avgs *continue* to decline .. which tells me .. that NR hasn't sold
anywhere near what they *allegedly* had access to .. which also tells me .. retention of the majority of those shares .. is deliberate because unlike so many OTC targets .. Innovation .. alongside her investors (not traders .. not crew) have outlasted NON RETAIL .. and that is truly unique when it comes to the OTC
and that was clear to me even before we got the news of the 8M *shares* ..
which leaves NR with very few options .. left to *work*
so you see new *aliases* try to embed this SMB (the other site has been useless for a dog's age) .. you see embeds trot out FTDs (as if they actually matter on an OTC) .. you see discussion of this divisive topic brought up deliberately by those who never offer any *factual* data .. rather trot out NRs' standard lines (sound bites)
every actual Innovation Investor knows why they remain invested
unlike many here who understand the science .. i remain invested due to mgmt's aggressive response to the blatant (but predictable) attack by NR in 2015 .. after NRs' last *significant* cycle (TAKE UP) of the back half of 2014 (just below 5.00)
mgmt's awareness of this illegal stock manipulation is as vital to the company's survival as their platforms are *imo*
and while the abusive short in IPIX is *less* than it would be *imo* due to access to those shares thru out the years .. it clearly exists .. because NR would *cover* the legal short that is currently reported .. if able to .. instead NR has had to *report* an increase over the last time frame .. vs a decrease .. and the reason the volume *decreases* is that NR is literally *stuck* in a hole of their own making
they can compress the PPS .. but retail will always pick off *shares* ... making that *hole* even deeper with news out of mgmt that *cant* be manipulated *down*
so NR deals with *reality* of marking at a higher and higher % .. on less and less *volume* .. and faces *imo .. (based on years of observations*) .. triggering reg sho .. quite possibly b4 news out of mgmt
now this is where it's going to be really interesting to see how *mgmt* handles aspects .. because in their shoes .. i'd be staggering news that allows NR no respite to *regroup* .. it's doable and i'm currently invested in a few other *survivors* whose mgmt has figured out the rigged game .. which has been my point all along
retail can learn where in the cycle NR is when it comes to any investment
so one isn't reduced to *whining* on SMBs .. or trolling others who *do* understand exactly what this data reveals ..
as always .. best to actual Innovation Pharma investors
4kids
11
